- Cybersecurity
- Data Governance
- Data Infrastructure
- Data Integration
- Data Lineage
- Data Management
- Electronic Health Record
- Encryption
Show all 16 topics
No article in the knowledge graph for RareCloud yet.
Who is RareCloud?
RareCloud is a privately held company that develops cloud-based health technology software for collecting, managing, and analyzing clinical and genomic data associated with rare diseases.
- Cloud-hosted health data platform for rare disease research and care
- Clinical and genomic data aggregation and normalization
- Patient registry and disease cohort management capabilities
- Role-based access controls and audit logging for regulated health data
- Analytics support for diagnostic and research workflows
Show more
More About RareCloud
In enterprise and research environments, offerings of this type are typically positioned for healthcare providers, academic medical centers, patient advocacy organizations, and life sciences companies that must consolidate fragmented data on low-prevalence conditions. The platform is generally used to support longitudinal patient records, registry construction, and cohort identification across multiple sites.
Cloud-hosted health data platforms in this area commonly rely on standards-based interoperability, such as HL7 FHIR for clinical data exchange and established genomic data formats for variant information. Deployments typically incorporate role-based access control, encryption in transit and at rest, and audit logging to address privacy and security obligations applicable to health information.
The category overlaps with clinical research data management systems, patient registry software, and health data integration tools. The primary distinction for buyers is the degree to which a platform handles genomic data and supports disease-specific cohort definition, rather than general-purpose clinical record storage.
The business significance of this approach lies in the structure of rare disease data. Because affected patient populations are small and geographically dispersed, information is often scattered across institutions and formats. Centralized, cloud-based aggregation can reduce that fragmentation, which supports earlier diagnosis, more complete natural history studies, and more efficient patient identification for research.
From an infrastructure perspective, scalability, data governance, and integration with existing electronic health record and laboratory systems are central evaluation criteria for enterprise architects and IT leaders. Platforms in this space are assessed on how well they maintain data lineage, support consent management, and expose data through documented interfaces.
Within the technology directory, the organization is positioned in health technology software, reflecting its current solution areas in clinical data management and rare disease analytics. This positioning aligns its offerings with healthcare IT buyers and life sciences organizations seeking structured, governed data infrastructure for specialized patient populations.
Our description of RareCloud. Updated October 2026.
